Vivus Investor Unveils Plans For $640M Buyout Offer
Private investment fund Aspen Investment LLC, one of Vivus Inc.'s largest shareholders, is considering offering to buy the "undervalued" pharmaceutical firm for $640 million, according to a Wednesday filing with the...To view the full article, register now.
Already a subscriber? Click here to view full article